Unknown

Dataset Information

0

Lactate dehydrogenase to albumin ratio as a prognostic factor for patients with severe infection requiring intensive care


ABSTRACT: Abstract This study was performed to verify whether lactate dehydrogenase to albumin (LDH/ALB) ratio could be used as an independent prognostic factor in patients with severe infection requiring intensive care. We reviewed electronic medical records of patients hospitalized to the intensive care unit via the emergency department with a diagnosis of infection between January 2014 and December 2019. From the collected data, ALB-based ratios (LDH/ALB, blood urea nitrogen to albumin, C-reactive protein to albumin, and lactate to albumin ratios) and some severity scores (modified early warning score, mortality in emergency department sepsis score [MEDS], and Acute Physiology And Chronic Health Evaluation II [APACHE II] score) were calculated. LDH/ALB ratio for predicting the in-hospital mortality was compared with other ALB-based ratios and severity scales by univariable and receiver-operating characteristics curve analysis. Modified severity scores by LDH/ALB ratio and multivariable logistic regression were used to verify the independence and usefulness of the LDH/ALB ratio. The median LDH/ALB ratio was higher in non-survivors than survivors (166.9 [interquartile range: 127.2–233.1] vs 214.7 [interquartile range: 160.2–309.7], P < .001). The area under the receiver-operating characteristics curve of the LDH/ALB ratio (0.642, 95% confidence interval: 0.602–0.681, P < .001) was not lower than that of other ALB-based ratios and severity scores. From multivariable logistic regression, LDH/ALB ratio was independently associated with in-hospital mortality (odds ratio = 1.001, 95% confidence interval: 1.000–1.002, P = .047). Area under the receiver-operating characteristics curves of MEDS and APACHE II scores were improved by modification with LDH/ALB ratio (MEDS: 0.643 vs 0.680, P < .001; APACHE II score: 0.675 vs 0.700, P = .003). LDH/ALB ratio may be useful as the prognostic factor in patients with severe infection requiring intensive care.

SUBMITTER: Jeon S 

PROVIDER: S-EPMC8519202 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9338032 | biostudies-literature
| S-EPMC10374360 | biostudies-literature
| S-EPMC9254365 | biostudies-literature
| S-EPMC2083622 | biostudies-literature
| S-EPMC10587476 | biostudies-literature
| S-EPMC8581292 | biostudies-literature
| S-EPMC7900153 | biostudies-literature
| S-EPMC10956288 | biostudies-literature
| PRJNA561526 | ENA